Abstract
Objectives To estimate the risk of radiation-induced lung cancer mortality from three annual low-dose lung computed tomography (CT) screens before age 55 years (starting at age 30, 40 or 50) and the mortality reduction from screening (i.e. the efficacy) needed to outweigh these risks for never and current-smokers. The risk of radiation-induced breast cancer was also estimated for women. Methods The Biological Effectiveness of Ionizing Radiation VII committee's risk models were used to estimate radiation risk. Lung cancer mortality rates (based on the Bach model for current and the Cancer Prevention Study for never-smokers) were used to estimate the mortality reduction needed to outweigh this risk. Results For never-smokers, the estimated excess lifetime risk of radiation-induced lung cancer mortality from annual screening aged 40–42 was 1/10,000 (90% credibility interval: 0.4–3) for men and 3/10,000 (2–6) for women. For current-smokers, the estimated risks were approximately two-fold higher, with wider credibility intervals. Risks from screening age 30–32 or 50–52 years were of similar magnitude. The mortality reduction required to outweigh these risks was, for female never-smokers: 125% (40–300%) age 30–32 years, 70% (30–190%) age 40–42 years and 25% (10–70%) age 50–52 years, and for male current-smokers: 70% (20–120%) age 30–32 years, 10% (3–20%) age 40–42 years and 2% (1–4%) age 50–52 years. These figures were two to three times higher for females because of the higher radiation risks. The risk of radiation-induced breast cancer was in the range of three to six cases/10,000 females screened. Conclusion Before age 50, the mortality reduction from lung CT screening that is required to outweigh the radiation risk may be substantial, and in some cases unattainable (i.e. >100%).
Keywords
Affiliated Institutions
Related Publications
Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)
Abstract A method to obtain the optimal selection criteria, taking into account available resources and capacity and the impact on power, is presented for the Dutch‐Belgian rand...
Cancer Statistics, 2009
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on...
The National Lung Screening Trial: Overview and Study Design
The National Lung Screening Trial (NLST) is a randomized multicenter study comparing low-dose helical computed tomography (CT) with chest radiography in the screening of older c...
Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives
Abstract BACKGROUND. The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Ca...
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically...
Publication Info
- Year
- 2008
- Type
- article
- Volume
- 15
- Issue
- 3
- Pages
- 153-158
- Citations
- 117
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1258/jms.2008.008052